Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 11:57 p.m.

    📋 Intra-Cellular Therapies, Inc. (ITCI) - Financial Results

    Filing Date: 2022-08-09

    Accepted: 2022-08-09 07:38:57

    Event Type: Financial Results

    Event Details:

    Intra-Cellular Therapies Inc (ITCI) Reports Q3 2022 Financial Results Intra-Cellular Therapies Inc (ITCI) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 4650
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 77235

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 69.85K 175.78K $-105.92K -60.26%
    Loss From Operations 69.14K 160.59K $-91.44K -56.94%
    Interest Income 421.00 1.87K $-1.45K -77.46%
    Net Loss 68.74K 158.72K $-89.98K -56.69%
    Current Assets Prepaid Expenses Other Current Assets 37.98K 25.44K $12.54K +49.27%
    Property Equipment Net 2.14K 1.79K $346.00 +19.32%
    Other Assets 86.00 86.00 $0.00 +0.00%
    Current Liabilities Accounts Payable 10.75K 8.69K $2.06K +23.68%
    Revenue 505.00 1.04K $-535.00 -51.44%
    Selling, General & Administrative 100.32K 69.85K $30.46K +43.61%
    Loss from Operations 87.92K 69.14K $18.78K +27.16%
    Interest Income 1.32K 421.00 $899.00 +213.54%
    Net Loss 86.60K 68.74K $17.86K +25.98%
    Prepaid Expenses and Other Current Assets 37.98K 25.44K $12.54K +49.27%
    Property and Equipment, Net 2.14K 1.79K $346.00 +19.32%
    Other Assets 86.00 86.00 $0.00 +0.00%
    Accounts Payable 10.75K 8.69K $2.06K +23.68%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Intra-Cellular Therapies Inc
    • CIK: 0001567514
    • Ticker Symbol: ITCI
    • Period End Date: 2022-08-09
    • Document Type: 8-K

Search

News categories